184 related articles for article (PubMed ID: 15246652)
1. HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy.
Matzen K; Dirkx AE; oude Egbrink MG; Speth C; Götte M; Ascherl G; Grimm T; Griffioen AW; Stürzl M
Virus Res; 2004 Sep; 104(2):145-55. PubMed ID: 15246652
[TBL] [Abstract][Full Text] [Related]
2. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis.
Lafrenie RM; Wahl LM; Epstein JS; Hewlett IK; Yamada KM; Dhawan S
J Immunol; 1996 Feb; 156(4):1638-45. PubMed ID: 8568270
[TBL] [Abstract][Full Text] [Related]
3. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression.
Lafrenie RM; Wahl LM; Epstein JS; Yamada KM; Dhawan S
J Immunol; 1997 Oct; 159(8):4077-83. PubMed ID: 9378998
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells.
Lee YW; Eum SY; Nath A; Toborek M
Cardiovasc Res; 2004 Jul; 63(1):139-48. PubMed ID: 15194470
[TBL] [Abstract][Full Text] [Related]
5. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
Barillari G; Buonaguro L; Fiorelli V; Hoffman J; Michaels F; Gallo RC; Ensoli B
J Immunol; 1992 Dec; 149(11):3727-34. PubMed ID: 1431144
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis.
Fiorelli V; Barillari G; Toschi E; Sgadari C; Monini P; Stürzl M; Ensoli B
J Immunol; 1999 Jan; 162(2):1165-70. PubMed ID: 9916748
[TBL] [Abstract][Full Text] [Related]
7. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B
J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes.
Weiss JM; Nath A; Major EO; Berman JW
J Immunol; 1999 Sep; 163(5):2953-9. PubMed ID: 10453044
[TBL] [Abstract][Full Text] [Related]
9. HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium.
Mrowiec T; Melchar C; Górski A
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):255-9. PubMed ID: 9597096
[TBL] [Abstract][Full Text] [Related]
10. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
[TBL] [Abstract][Full Text] [Related]
11. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.
Barillari G; Gendelman R; Gallo RC; Ensoli B
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7941-5. PubMed ID: 7690138
[TBL] [Abstract][Full Text] [Related]
12. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.
Ensoli B; Barillari G; Salahuddin SZ; Gallo RC; Wong-Staal F
Nature; 1990 May; 345(6270):84-6. PubMed ID: 2184372
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production.
Contreras X; Bennasser Y; Chazal N; Moreau M; Leclerc C; Tkaczuk J; Bahraoui E
Virology; 2005 Feb; 332(1):316-28. PubMed ID: 15661163
[TBL] [Abstract][Full Text] [Related]
14. Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase.
Fotheringham J; Mayne M; Holden C; Nath A; Geiger JD
Virology; 2004 Oct; 327(2):186-95. PubMed ID: 15351206
[TBL] [Abstract][Full Text] [Related]
15. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
[TBL] [Abstract][Full Text] [Related]
16. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes.
Lafrenie RM; Wahl LM; Epstein JS; Hewlett IK; Yamada KM; Dhawan S
J Immunol; 1996 Aug; 157(3):974-7. PubMed ID: 8757599
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 tat protein modulates fibronectin expression in thymic epithelial cells and impairs in vitro thymocyte development.
Maroder M; Scarpa S; Screpanti I; Stigliano A; Meco D; Vacca A; Stuppia L; Frati L; Modesti A; Gulino A
Cell Immunol; 1996 Feb; 168(1):49-58. PubMed ID: 8599839
[TBL] [Abstract][Full Text] [Related]
18. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 (HIV-1) tat-protein stimulates the production of interleukin-6 (IL-6) by peripheral blood monocytes.
Zauli G; Furlini G; Re MC; Milani D; Capitani S; La Placa M
New Microbiol; 1993 Apr; 16(2):115-20. PubMed ID: 8510564
[TBL] [Abstract][Full Text] [Related]
20. The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein.
Cantaluppi V; Deregibus MC; Biancone L; Deambrosis I; Bussolati B; Albini A; Camussi G
Int J Immunopathol Pharmacol; 2006; 19(1):81-96. PubMed ID: 16569346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
